| Parameters |
| Age (yr), mean (SD) | 39.39 (15.82) | Sex | Male, n (%) | 35 (33.3) | Female, n (%) | 70 (66.7) | BMI, mean (SD) | 24.57 (2.7) |
| Comorbidity | At least one comorbidity, n (%) | 44 (41.9) | Smoking, n (%) | 3 (2.9) | Addiction | 1 (0.9) | DM, n (%) | 9 (8.6) | HTN, n (%) | 11 (10.5) | DLP, n (%) | 10 (9.5) | IHD, n (%) | 2 (1.9) | Thyroid disorder, n (%) | 8 (7.6) | Depression, n (%) | 2 (1.9) | Asthma, n (%) | 6 (5.7) | Sinusitis, n(%) | 3 (2.8) | IBD, n (%) | 2 (1.9) | Allergy history, n (%) | 10 (9.5) | AD, n (%) | 1 (0.9) |
| Clinical symptoms | Fever, n (%) | 37 (35.2) | Sore throat, n (%) | 71 (67.6) | Cough, n (%) | 63 (60) | Chest pain, n (%) | 35 (33.3) | Dyspnea, n (%) | 42 (40) | Runny nose, n (%) | 7 (6.7) | Fatigue, n (%) | 82 (78.1) | Headache, n (%) | 53 (50.5) | Myalgia, n (%) | 58 (55.2) | Vertigo, n (%) | 16 (15.2) | Dyspepsia, n (%) | 5 (17) | Diarrhea, n (%) | 25 (23.8) | Nausea, n (%) | 12 (11.4) | Loss of appetite, n (%) | 41 (39) | Anosmia, n (%) | 36 (34.3) | Ageusia, n (%) | 32 (30.5) | Excessive sweeting, n (%) | 12 (11.4) | Skin rash, n (%) | 5 (4.8) | Red eyes, n (%) | 4 (3.8) |
| COVID-19 data | COVID-19 contact history | Travel history, n (%) | 2 (1.9) | Family member, n (%) | 26 (24.8) | Attending a party, n (%) | 8 (7.6) | Unknown, n (%) | 69 (65.7) |
| COVID-19 confirmation | Lung CT scan involvement, n (%) | 105 (100) | RT-PCR, n (%) | 41 (39) |
|
|